Companies: 10,795·Total market cap: $144.5T
HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLS.TOTSXHealthcare● Active
$4.40
$-0.07(-1.57%)
Market Cap$137604280
P/E Ratio—
52W High$5.765
52W Low$0.001
Overview
股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

HLS Therapeutics Inc.（HLS.TO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HLS.TO · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.32hls.to eps ttm · hls.to earnings per shareEarnings history
PE Ratio (TTM)—hls.to pe ratio ttm · hls.to price to earningsPE Ratio deep dive
Revenue (TTM)$55.8Mhls.to revenue ttm · hls.to annual revenueFull revenue history
Dividend Yield3.42%does hls.to pay dividends · hls.to dividend yieldDividend history
Shares Outstanding31.5Mhls.to shares outstanding · hls.to floatShares outstanding history
Next EarningsAug 13, 2026Est.hls.to earnings date · hls.to next earningsEarnings history

探索 HLS Therapeutics Inc. 数据

hls.to stock data · financials
市值$137.6Mhls.to market cap · hls.to valuation
分析师预测$— · Hold
股息3.42%does hls therapeutics inc. pay dividends · hls.to dividend yield
营收$56.5M-0.26%hls therapeutics inc. annual revenue · hls.to revenue
盈利EPS $-0.40+35.48%hls.to earnings · hls.to eps
市盈率—hls.to pe ratio · hls.to price to earnings

财务快照

完整财报
FY 2025Revenue$56.5M▼ 0.26% YoY
202320242025
hls therapeutics inc. revenue · hls.to revenue 2025
FY 2025Net Income-$12.6M▲ +35.65% YoY
202320242025
hls therapeutics inc. net income · hls.to profit 2025
FY 2025EPS$-0.40▲ +35.48% YoY
202320242025
hls.to eps · hls therapeutics inc. earnings per share 2025
TTM:Revenue: $55.8MNet Income: -$10.3MEPS: $-0.32View income statement →

分析师评级与目标价

完整预测
SellBuy
Hold1 位分析师is hls.to a buy · hls.to analyst rating
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$4.40Current
$—Avg Target
$—High
hls.to price target · hls.to 12 month forecast

合计: 1 · 买入占比: 0.0%

股票表现

完整历史
1D+0.90%
1W+1.36%
1M-4.69%
3M+2.52%
YTD-7.26%
1Y-10.24%
5Y-75.24%

关于 HLS Therapeutics Inc.

CEOCraig Stuart Millian
IPO DateMar 14, 2018
Employees92
CountryCA
Websitehlstherapeutics.com

HLS Therapeutics Inc. a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the Un…

Drug Manufacturers - Specialty & GenericHealthcareTSXCA

what is hls therapeutics inc. · hls.to stock overview · hls therapeutics inc. company profile · who is hls therapeutics inc. ceo · hls.to TSX · hls therapeutics inc. headquarters · hls therapeutics inc. business segments

关于股票概览与关键数据

HLS Therapeutics Inc.（HLS.TO）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Mar 14, 2018 在 TSX 上市。截至最近交易日，HLS.TO 股价为 $4.40，市值约为 $137.6M。过去12个月累计回报 -10.24%，年初至今回报 -7.26%。

根据 1 位华尔街分析师，HLS Therapeutics Inc. 股票共识评级为Hold，12个月平均目标价为 $—。2025 财年 HLS Therapeutics Inc. 营收 $56.5M，净利润 -$12.6M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，HLS Therapeutics Inc.（HLS.TO）股价为 $4.40，在 TSX 上市，52周区间为 $0.00 – $5.76。

HLS.TO 最新股价HLS.TO quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议